When Sarah, a mother of two, was diagnosed with breast cancer in 2021 at the age of 43, she carefully considered where to go for care.
She had been referred by her doctor to Beth Israel Deaconess Medical Center, where she received a mammogram and the cancer diagnosis. But Sarah, who asked that her last name not be used, ultimately chose the Dana-Farber Cancer Institute, wanting a place that was known for cancer treatment.
Like many cancer patients, Sarah’s treatment at Dana-Farber was co-managed by its longtime medical partner, Brigham and Women’s Hospital: Her three surgeries were performed at the Brigham, by Brigham doctors; her five rounds of chemotherapy at Dana-Farber. She found the care as integrated and connected as the skybridge walkway that physically knits the two buildings together, she said.